SRSF3-mediated post-transcriptional regulation of SERPINH1 promotes tumor growth and immune evasion in hepatocellular carcinoma
Year: 2026
Type: article
Abstract: Hepatocellular carcinoma (HCC) is characterized by aggressive progression and a profoundly immunosuppressive tumor microenvironment (TME). Serine/arginine-rich splicing factor 3 (SRSF3) is a key regulator of alternative splicing, yet its role in shaping the immune microenvironment and fibrotic remodeling in HCC remains poorly understood. SRSF3 expression was examined in human HCC tissues and cell lines by immunohistochemistry, qPCR, and Western blot. Gain- and loss-of-function approaches were used to evaluate the effects of SRSF3 on HCC cell proliferation, migration, invasion, and cytokine secretion in vitro. RNA immunoprecipitation was performed to assess the interaction between SRSF3 and SERPINH1 mRNA. Tumor growth, immune cell infiltration, and fibrosis were analyzed in mouse tumor models with SRSF3 manipulation or overexpression of distinct SERPINH1 isoforms using flow cytometry, histology, and immunofluorescence. SRSF3 was markedly upregulated in HCC tissues and correlated with poor prognosis, reduced cytotoxic immune infiltration, increased regulatory T cells, and elevated PD-L1 expression. Functionally, SRSF3 promoted HCC cell proliferation, migration, invasion, and secretion of immunosuppressive cytokines. In vivo, SRSF3 accelerated tumor growth and reshaped the TME toward an immunosuppressive phenotype. Mechanistically, SRSF3 directly bound to SERPINH1 mRNA and enhanced its expression. Among SERPINH1 isoforms, the short isoform exerted the strongest pro-tumorigenic and pro-fibrotic effects, promoting collagen deposition, tumor proliferation, and immune exclusion. Our findings identify SRSF3 as a critical driver of HCC progression by orchestrating tumor growth, fibrosis, and immune evasion through regulation of SERPINH1, particularly its short isoform. Targeting the SRSF3–SERPINH1 axis may represent a promising strategy to simultaneously inhibit tumor progression and improve antitumor immune responses in HCC.
Source: Scientific Reports
Authors: Hui Yan, Limin Zhu, Bin Liu, Qing Liu
Language: English
Topic: RNA Research and Splicing
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7233588656
FWCI:
Cites:
Cited by:
Related to:
